Why Choose SCORR Marketing?
Industry Focus
SCORR specializes in supporting drug development, clinical trial, medical device, CDMO, CRO, and other organizations who are looking to scale and expand.
Proven Results
For more than 20 years, SCORR has helped more than 300 life science and medical device companies achieve their marketing goals.
Client Satisfaction
SCORR outranks competitors across all performance indicators.
SCORR Core Is Comprised of Four Phases
SCORR employs a strategic approach to help you achieve your goals. Our proven process is disciplined and collaborative, delivering the incremental growth that has successfully branded and guided hundreds of life science companies of all sizes around the world.
ASSESS
- Internal Assessments
- Voice of Customer
- Competitive Analysis
- Market Assessment
ALIGN
- Identity Development
- Big Idea: Branding/Campaign
- Annual Strategic Marketing Action Plan
INTEGRATE
- Foundational/Launch Materials
- Deploy Marketing Tactics
LEVERAGE
- Ongoing Management
- Track and Measure
SCORR’s Life Cycle Management Process
The life cycle management process speaks to the two largest pain points our clients have identified: brand awareness and filling the pipeline. We address both of these areas simultaneously in an integrated way to ensure the strategy and tactics are executed together seamlessly. By integrating these ongoing awareness and lead generation tactics, prospects can be nurtured into a loyal client, which in turn will yield more referrals, thus feeding into the funnel again.
Our Mission
To be our clients’ competitive advantage as a full-service marketing solution with a powerhouse of experts deploying integrated programs to drive results, increase their value, and help them improve health and well-being worldwide.
The Milestones to Creating the Leader in Life Science Marketing
2003
Cinda Orr founds SCORR Marketing.
2004
Chief Creative Officer Ben Rowe joins Cinda and they open the Kearney, Neb., headquarters.
2005
Krystle Buntemeyer joins SCORR as client service lead, building the team, services, and program offerings.
2007
Opens second office in Omaha, Neb., and manages Bio Nebraska for the state of Nebraska from that office.
2008
Expands reach into Europe and Asia.
2014
Establishes a strategic advisory board comprising industry leadership from various drug development organizations.
2017
Launched the Bridging Clinical Research and Clinical Care Collaborative and hosted event for three years and in 2020-2021 joined with the Clinical Research as a Care Option (CRAACO) conference.
2019
Reaches 300th client milestone and 30th M&A branding/communication program.
2020
Cinda is honored in PharmaVOICE’s 2020 Top 100.
2021
300+ marketing awards for creative and strategic work.
2021
Partnered with MedExecWomen organization.
2021
65+ employees utilize a formal drug development training and learning curriculum.
2022
90+ clients supported through an M&A or significant growth phase.
2023
Krystle Buntemeyer is appointed CEO and Lea LaFerla is named president.
2024
SCORR’s initiative, Clinical Trials For All, has achieved a significant milestone by partnering with over 70 organizations within its first year of being publicly launched.